Impact Factor 4.416
2017 JCR, Clarivate Analytics 2018

Frontiers journals are at the top of citation and impact metrics

Correction ARTICLE

Front. Oncol., 05 June 2018 | https://doi.org/10.3389/fonc.2018.00201

Corrigendum: Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma

imageDaniel Benitez-Ribas1, imageRaquel Cabezón1, imageGeorgina Flórez-Grau1, imageMari Carmen Molero2, imagePatricia Puerta3, imageAntonio Guillen3, imageE. Azucena González-Navarro1, imageSonia Paco4,5, imageAngel M. Carcaboso4,5, imageVicente Santa-Maria Lopez5,6, imageOfelia Cruz5,6, imageCarmen de Torres4,5, imageNoelia Salvador4,5, imageManel Juan1,7*, imageJaume Mora4,5 and imageAndres Morales La Madrid4,5,6*
  • 1Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain
  • 2Department of Clinical Trials, Hospital Sant Joan de Déu, Barcelona, Spain
  • 3Department of Neurosurgery, Hospital Sant Joan de Déu, Barcelona, Spain
  • 4Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain
  • 5Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain
  • 6Department of Neuro-Oncology, Hospital Sant Joan de Déu, Barcelona, Spain
  • 7Department of Immunotherapy, Hospital Sant Joan de Déu, Barcelona, Spain

A corrigendum on

Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma
by Benitez-Ribas D, Cabezón R, Flórez-Grau G, Molero MC, Puerta P, Guillen A, et al. Front Oncol (2018) 8:127. doi: 10.3389/fonc.2018.00127

E. Azucena González-Navarro was not included as an author in the published article. The correct author contributions statement appears below:

Author Contributions

MJ, DB-R, JM, OC, AMC and AMLM designed the study. PP and AG procured the tumor specimens for the cell lines, and CdT and NS characterized molecularly the samples. SP and ACM established the cell lines and tumor lysate. RC, GF-G, EA G-N and DB-R prepared the vaccines. MM, OC, VSM, and AMLM obtained clinical and laboratory data. RC, GF-G, EA G-N and DB-R analyzed immunologic data. MJ, DB-R, OC, JM, ACM and AMLM prepared the original manuscript. All authors provided manuscript review and approval.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

The original article has been updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: immunotherapy, dendritic, cell, vaccination, diffuse intrinsic pontine glioma

Citation: Benitez-Ribas D, Cabezón R, Flórez-Grau G, Molero MC, Puerta P, Guillen A, González-Navarro EA, Paco S, Carcaboso AM, Santa-Maria Lopez V, Cruz O, de Torres C, Salvador N, Juan M, Mora J and Morales La Madrid A (2018) Corrigendum: Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma. Front. Oncol. 8:201. doi: 10.3389/fonc.2018.00201

Received: 03 May 2018; Accepted: 18 May 2018;
Published: 05 June 2018

Copyright: © 2018 Benitez-Ribas, Cabezón, Flórez-Grau, Molero, Puerta, Guillen, González-Navarro, Paco, Carcaboso, Santa-Maria Lopez, Cruz, de Torres, Salvador, Juan, Mora and Morales La Madrid. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Approved by:

Frontiers in Oncology Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Manel Juan, mjuan@clinic.cat;
Andres Morales La Madrid, amorales@hsjdbcn.org